US Stock MarketDetailed Quotes

SNOA Sonoma Pharmaceuticals

Watchlist

0.2479
-0.0608-19.70%

Close Aug 9 16:00 ET

0.2450
-0.0029-1.17%

Post 19:59 ET

4.75MMarket Cap-799P/E (TTM)

Sonoma Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-324.19%-912K

61.02%-2.4M

106.23%152K

-217.24%-1.1M

32.73%-1.23M

85.98%-215K

-44.82%-6.15M

-74.98%-2.44M

-6.75%-348K

-40.34%-1.83M

Net income from continuing operations

19.39%-1.14M

6.13%-4.84M

18.43%-1.07M

55.34%-866K

-45.92%-1.48M

-59.86%-1.42M

-1.28%-5.15M

55.57%-1.31M

-105.40%-1.94M

-917.00%-1.02M

Operating gains losses

----

99.86%-1K

----

Depreciation and amortization

-13.33%39K

40.80%176K

20.59%41K

40.63%45K

60.71%45K

45.16%45K

-32.80%125K

-30.61%34K

-13.51%32K

-46.15%28K

Deferred tax

35.56%122K

-194.59%-109K

-197.10%-201K

----

325.00%90K

95.54%-37K

--207K

----

Other non cash items

-30.38%55K

-6.94%161K

----

--79K

-22.42%173K

----

Change In working capital

-111.33%-92K

187.72%1.69M

169.81%1.15M

-132.99%-515K

124.85%247K

195.42%812K

-161.64%-1.93M

-150.24%-1.65M

131.26%1.56M

-69.05%-994K

-Change in receivables

-346.07%-470K

-5,650.00%-230K

93.23%-9K

-306.23%-596K

311.49%184K

361.64%191K

-100.20%-4K

-106.55%-133K

-46.18%289K

81.99%-87K

-Change in inventory

-149.57%-114K

--184K

70.99%277K

-274.04%-496K

163.60%173K

231.43%230K

--0

-39.10%162K

166.90%285K

-494.20%-272K

-Change in prepaid assets

170.24%59K

461.76%1.11M

163.90%561K

185.14%499K

-72.30%131K

-10.53%-84K

33.48%-306K

-52.96%-878K

-55.92%175K

785.51%473K

-Change in payables and accrued expense

-6.98%480K

163.34%216K

116.53%98K

-85.13%101K

52.88%-499K

-18.35%516K

-138.66%-341K

-189.71%-593K

534.58%679K

-2,202.17%-1.06M

-Change in other current assets

----

-72.60%20K

----

1.39%73K

-211.11%-10K

-Change in other current liabilities

30.38%-55K

6.94%-161K

21.52%-62K

71.83%-20K

--0

15.96%-79K

22.07%-173K

-2.60%-79K

0.00%-71K

987.50%71K

-Change in other working capital

-78.95%8K

152.17%577K

1,335.48%383K

-117.56%-23K

262.73%179K

103.47%38K

-204.34%-1.11M

-102.77%-31K

122.03%131K

-83.33%-110K

Cash from discontinued investing activities

Operating cash flow

-324.19%-912K

61.02%-2.4M

106.23%152K

-217.24%-1.1M

32.73%-1.23M

85.98%-215K

-44.82%-6.15M

-74.98%-2.44M

-6.75%-348K

-40.34%-1.83M

Investing cash flow

Cash flow from continuing investing activities

70.59%-5K

99.22%-2K

121.95%18K

-102.94%-1K

98.93%-2K

26.09%-17K

-160.61%-258K

-34.43%-82K

34K

-1,800.00%-187K

Net PPE purchase and sale

70.59%-5K

93.68%-17K

101.58%3K

96.77%-1K

92.00%-2K

26.09%-17K

-96.35%-269K

-206.45%-190K

-3,000.00%-31K

0.00%-25K

Net other investing changes

----

36.36%15K

----

-71.05%11K

10,700.00%108K

6,400.00%65K

----

Cash from discontinued investing activities

Investing cash flow

70.59%-5K

99.22%-2K

121.95%18K

-102.94%-1K

98.93%-2K

26.09%-17K

-160.61%-258K

-34.43%-82K

--34K

-1,800.00%-187K

Financing cash flow

Cash flow from continuing financing activities

571.11%636K

-32.66%1.68M

-81.55%622K

514.47%1.32M

27.53%-129K

65.12%-135K

-66.35%2.49M

1,418.92%3.37M

-168.68%-318K

-102.57%-178K

Net issuance payments of debt

8.46%-119K

46.20%-481K

6.00%-94K

44.10%-128K

40.00%-129K

62.86%-130K

-139.04%-894K

-145.05%-100K

-15.08%-229K

-8.59%-215K

Net common stock issuance

15,060.00%748K

-37.80%1.78M

-88.21%338K

--1.45M

--0

---5K

-62.03%2.87M

--2.87M

--0

Proceeds from stock option exercised by employees

--7K

----

--0

----

Net other financing activities

----

-27.57%373K

-37.42%378K

----

--515K

--604K

----

Cash from discontinued financing activities

Financing cash flow

571.11%636K

-32.66%1.68M

-81.55%622K

514.47%1.32M

27.53%-129K

65.12%-135K

-66.35%2.49M

1,418.92%3.37M

-168.68%-318K

-102.57%-178K

Net cash flow

Beginning cash position

-18.12%3.13M

-48.35%3.82M

-8.66%2.41M

-36.23%2.14M

-36.56%3.54M

-48.35%3.82M

75.26%7.4M

-69.12%2.63M

-60.07%3.35M

98.72%5.59M

Current changes in cash

23.43%-281K

81.54%-724K

-6.71%792K

133.70%213K

37.95%-1.36M

81.11%-367K

-228.60%-3.92M

168.80%849K

-561.31%-632K

-139.01%-2.2M

Effect of exchange rate changes

-383.52%-258K

-90.72%32K

-120.77%-70K

165.88%56K

-12.50%-45K

-31.58%91K

171.65%345K

233.66%337K

---85K

13.04%-40K

End cash Position

-26.95%2.59M

-18.12%3.13M

-8.66%2.41M

-36.23%2.14M

-36.56%3.54M

-48.35%3.82M

-69.12%2.63M

-60.07%3.35M

Free cash flow

-295.26%-917K

62.39%-2.42M

105.89%155K

-191.56%-1.11M

33.53%-1.23M

85.09%-232K

-46.43%-6.42M

-80.58%-2.63M

-15.90%-379K

-39.58%-1.86M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-324.19%-912K	61.02%-2.4M	106.23%152K	-217.24%-1.1M	32.73%-1.23M	85.98%-215K	-44.82%-6.15M	-74.98%-2.44M	-6.75%-348K	-40.34%-1.83M
Net income from continuing operations	19.39%-1.14M	6.13%-4.84M	18.43%-1.07M	55.34%-866K	-45.92%-1.48M	-59.86%-1.42M	-1.28%-5.15M	55.57%-1.31M	-105.40%-1.94M	-917.00%-1.02M
Operating gains losses	----	----	----	----	----	----	99.86%-1K	----	----	----
Depreciation and amortization	-13.33%39K	40.80%176K	20.59%41K	40.63%45K	60.71%45K	45.16%45K	-32.80%125K	-30.61%34K	-13.51%32K	-46.15%28K
Deferred tax	35.56%122K	-194.59%-109K	-197.10%-201K	----	----	325.00%90K	95.54%-37K	--207K	----	----
Other non cash items	-30.38%55K	-6.94%161K	----	----	----	--79K	-22.42%173K	----	----	----
Change In working capital	-111.33%-92K	187.72%1.69M	169.81%1.15M	-132.99%-515K	124.85%247K	195.42%812K	-161.64%-1.93M	-150.24%-1.65M	131.26%1.56M	-69.05%-994K
-Change in receivables	-346.07%-470K	-5,650.00%-230K	93.23%-9K	-306.23%-596K	311.49%184K	361.64%191K	-100.20%-4K	-106.55%-133K	-46.18%289K	81.99%-87K
-Change in inventory	-149.57%-114K	--184K	70.99%277K	-274.04%-496K	163.60%173K	231.43%230K	--0	-39.10%162K	166.90%285K	-494.20%-272K
-Change in prepaid assets	170.24%59K	461.76%1.11M	163.90%561K	185.14%499K	-72.30%131K	-10.53%-84K	33.48%-306K	-52.96%-878K	-55.92%175K	785.51%473K
-Change in payables and accrued expense	-6.98%480K	163.34%216K	116.53%98K	-85.13%101K	52.88%-499K	-18.35%516K	-138.66%-341K	-189.71%-593K	534.58%679K	-2,202.17%-1.06M
-Change in other current assets	----	----	----	-72.60%20K	----	----	----	----	1.39%73K	-211.11%-10K
-Change in other current liabilities	30.38%-55K	6.94%-161K	21.52%-62K	71.83%-20K	--0	15.96%-79K	22.07%-173K	-2.60%-79K	0.00%-71K	987.50%71K
-Change in other working capital	-78.95%8K	152.17%577K	1,335.48%383K	-117.56%-23K	262.73%179K	103.47%38K	-204.34%-1.11M	-102.77%-31K	122.03%131K	-83.33%-110K
Cash from discontinued investing activities
Operating cash flow	-324.19%-912K	61.02%-2.4M	106.23%152K	-217.24%-1.1M	32.73%-1.23M	85.98%-215K	-44.82%-6.15M	-74.98%-2.44M	-6.75%-348K	-40.34%-1.83M
Investing cash flow
Cash flow from continuing investing activities	70.59%-5K	99.22%-2K	121.95%18K	-102.94%-1K	98.93%-2K	26.09%-17K	-160.61%-258K	-34.43%-82K	34K	-1,800.00%-187K
Net PPE purchase and sale	70.59%-5K	93.68%-17K	101.58%3K	96.77%-1K	92.00%-2K	26.09%-17K	-96.35%-269K	-206.45%-190K	-3,000.00%-31K	0.00%-25K
Net other investing changes	----	36.36%15K	----	----	----	----	-71.05%11K	10,700.00%108K	6,400.00%65K	----
Cash from discontinued investing activities
Investing cash flow	70.59%-5K	99.22%-2K	121.95%18K	-102.94%-1K	98.93%-2K	26.09%-17K	-160.61%-258K	-34.43%-82K	--34K	-1,800.00%-187K
Financing cash flow
Cash flow from continuing financing activities	571.11%636K	-32.66%1.68M	-81.55%622K	514.47%1.32M	27.53%-129K	65.12%-135K	-66.35%2.49M	1,418.92%3.37M	-168.68%-318K	-102.57%-178K
Net issuance payments of debt	8.46%-119K	46.20%-481K	6.00%-94K	44.10%-128K	40.00%-129K	62.86%-130K	-139.04%-894K	-145.05%-100K	-15.08%-229K	-8.59%-215K
Net common stock issuance	15,060.00%748K	-37.80%1.78M	-88.21%338K	--1.45M	--0	---5K	-62.03%2.87M	--2.87M	--0	--0
Proceeds from stock option exercised by employees	--7K	----	----	----	----	--0	----	----	----	----
Net other financing activities	----	-27.57%373K	-37.42%378K	----	----	----	--515K	--604K	----	----
Cash from discontinued financing activities
Financing cash flow	571.11%636K	-32.66%1.68M	-81.55%622K	514.47%1.32M	27.53%-129K	65.12%-135K	-66.35%2.49M	1,418.92%3.37M	-168.68%-318K	-102.57%-178K
Net cash flow
Beginning cash position	-18.12%3.13M	-48.35%3.82M	-8.66%2.41M	-36.23%2.14M	-36.56%3.54M	-48.35%3.82M	75.26%7.4M	-69.12%2.63M	-60.07%3.35M	98.72%5.59M
Current changes in cash	23.43%-281K	81.54%-724K	-6.71%792K	133.70%213K	37.95%-1.36M	81.11%-367K	-228.60%-3.92M	168.80%849K	-561.31%-632K	-139.01%-2.2M
Effect of exchange rate changes	-383.52%-258K	-90.72%32K	-120.77%-70K	165.88%56K	-12.50%-45K	-31.58%91K	171.65%345K	233.66%337K	---85K	13.04%-40K
End cash Position	-26.95%2.59M	-18.12%3.13M	-18.12%3.13M	-8.66%2.41M	-36.23%2.14M	-36.56%3.54M	-48.35%3.82M	-48.35%3.82M	-69.12%2.63M	-60.07%3.35M
Free cash flow	-295.26%-917K	62.39%-2.42M	105.89%155K	-191.56%-1.11M	33.53%-1.23M	85.09%-232K	-46.43%-6.42M	-80.58%-2.63M	-15.90%-379K	-39.58%-1.86M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall